Eco Animal Health Gp - Posting of Annual Report and Notice of AGM

ECO Animal Health

28/08/2025 07:48

RNS Number : 0258X

Eco Animal Health Group PLC

28 August 2025

 

28 August 2025

ECO Animal Health Group plc

("ECO" or the "Company")

 

Posting of Annual Report and Notice of AGM

​

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that its Annual Report and Accounts for the year ended 31 March 2025 ("Annual Report"), Notice of Annual General Meeting ("AGM") and Form of Proxy have today been posted to shareholders who have elected to receive hard copies by post.

The Company will hold its AGM at The Grange, 100 High Street, London, N14 6BN on Thursday 25 September 2025 at 09.00am.

The Annual Report, Notice of AGM and Form of Proxy will be made available on the Company's website at https://ecoanimalhealth.com/investors/.

-Ends-

 

Contacts

ECO Animal Health Group plc
David Hallas (Chief Executive Officer)
Christopher Wilks (Chief Financial Officer)
020 8447 8899
ICR Healthcare (Financial PR)
Mary-Jane Elliott
Jessica Hodgson
020 3709 5700
Singer Capital Markets (Nominated Adviser & Joint Broker)
Philip Davies
Sam Butcher
020 7496 3000
Investec (Joint Broker)
Gary Clarence
Lydia Zychowska
020 7597 5970
Equity Development
Hannah Crowe
Matt Evans
020 7065 2692

 



About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

 

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

 

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

 

Click here for more information: https://ecoanimalhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NOAPKFBQABKKPFB